DPP4 inhibition affects metabolism and inflammation associated pathways in hiPSC-derived steatotic HLCs
Christiane Loerch, Wasco Wruck, Annika Wittich, Rabea Hokamp, Julian Reiss, Ole Pleß, James Adjaye, Nina Graffmann
This study shows DPP4 inhibition alters metabolism and inflammation pathways in steatotic hiPSC-derived HLCs, suggesting potential therapeutic benefits for MAFLD.
Frontiers in Cell and Developmental Biology · Feb 26, 2026Peer-reviewedCell Biology